| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| BATF3 | IFNG | ENSNLEP00000026557 | ENSNLEP00000004233 | Basic leucine zipper ATF-like transcription factor 3. | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons. | 0.453 |
| BATF3 | IRF8 | ENSNLEP00000026557 | ENSNLEP00000013911 | Basic leucine zipper ATF-like transcription factor 3. | Interferon regulatory factor 8. | 0.644 |
| ETV3 | IRF8 | ENSNLEP00000040431 | ENSNLEP00000013911 | ETS variant 3. | Interferon regulatory factor 8. | 0.647 |
| ETV3 | RUNX1 | ENSNLEP00000040431 | ENSNLEP00000041433 | ETS variant 3. | Runt-related transcription factor; Forms the heterodimeric complex core-binding factor (CBF) with CBFB. RUNX members modulate the transcription of their target genes through recognizing the core consensus binding sequence 5'- TGTGGT-3', or very rarely, 5'-TGCGGT-3', within their regulatory regions via their runt domain, while CBFB is a non-DNA-binding regulatory subunit that allosterically enhances the sequence-specific DNA-binding capacity of RUNX. | 0.488 |
| IFNG | BATF3 | ENSNLEP00000004233 | ENSNLEP00000026557 | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons. | Basic leucine zipper ATF-like transcription factor 3. | 0.453 |
| IFNG | IRF1 | ENSNLEP00000004233 | ENSNLEP00000015443 | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons. | Interferon regulatory factor. | 0.741 |
| IFNG | IRF8 | ENSNLEP00000004233 | ENSNLEP00000013911 | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons. | Interferon regulatory factor 8. | 0.715 |
| IFNG | RUNX1 | ENSNLEP00000004233 | ENSNLEP00000041433 | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons. | Runt-related transcription factor; Forms the heterodimeric complex core-binding factor (CBF) with CBFB. RUNX members modulate the transcription of their target genes through recognizing the core consensus binding sequence 5'- TGTGGT-3', or very rarely, 5'-TGCGGT-3', within their regulatory regions via their runt domain, while CBFB is a non-DNA-binding regulatory subunit that allosterically enhances the sequence-specific DNA-binding capacity of RUNX. | 0.744 |
| IFNG | SPI1 | ENSNLEP00000004233 | ENSNLEP00000017707 | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons. | Spi-1 proto-oncogene. | 0.448 |
| IFNG | STAT1 | ENSNLEP00000004233 | ENSNLEP00000034193 | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons. | Signal transducer and activator of transcription. | 0.866 |
| IFNG | STAT2 | ENSNLEP00000004233 | ENSNLEP00000026065 | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons. | Signal transducer and activator of transcription. | 0.769 |
| IFNG | TRAF6 | ENSNLEP00000004233 | ENSNLEP00000021805 | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons. | TNF receptor-associated factor; Belongs to the TNF receptor-associated factor family. | 0.650 |
| IRF1 | IFNG | ENSNLEP00000015443 | ENSNLEP00000004233 | Interferon regulatory factor. | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons. | 0.741 |
| IRF1 | IRF8 | ENSNLEP00000015443 | ENSNLEP00000013911 | Interferon regulatory factor. | Interferon regulatory factor 8. | 0.905 |
| IRF1 | RUNX1 | ENSNLEP00000015443 | ENSNLEP00000041433 | Interferon regulatory factor. | Runt-related transcription factor; Forms the heterodimeric complex core-binding factor (CBF) with CBFB. RUNX members modulate the transcription of their target genes through recognizing the core consensus binding sequence 5'- TGTGGT-3', or very rarely, 5'-TGCGGT-3', within their regulatory regions via their runt domain, while CBFB is a non-DNA-binding regulatory subunit that allosterically enhances the sequence-specific DNA-binding capacity of RUNX. | 0.518 |
| IRF1 | SPI1 | ENSNLEP00000015443 | ENSNLEP00000017707 | Interferon regulatory factor. | Spi-1 proto-oncogene. | 0.838 |
| IRF1 | STAT1 | ENSNLEP00000015443 | ENSNLEP00000034193 | Interferon regulatory factor. | Signal transducer and activator of transcription. | 0.990 |
| IRF1 | STAT2 | ENSNLEP00000015443 | ENSNLEP00000026065 | Interferon regulatory factor. | Signal transducer and activator of transcription. | 0.894 |
| IRF1 | TRAF6 | ENSNLEP00000015443 | ENSNLEP00000021805 | Interferon regulatory factor. | TNF receptor-associated factor; Belongs to the TNF receptor-associated factor family. | 0.429 |
| IRF8 | BATF3 | ENSNLEP00000013911 | ENSNLEP00000026557 | Interferon regulatory factor 8. | Basic leucine zipper ATF-like transcription factor 3. | 0.644 |